Product Information
ERYTHROMYCIN DR 333 MG TABLET is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $3.5825 per EA under NDC 52536018303. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
333 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536018303
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298FDA Approved
Before 1982
TE Code
AB
On Market Since
7/22/2019
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 333 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5825 per EA |
|---|---|
| All-time high | $3.9058 (Dec 11, 2024) |
| All-time low | $2.5179 (Aug 21, 2024) |
| 52-week high | $3.7275 |
| 52-week low | $3.3321 |
| Median price | $3.4358 |
| Average price | $3.3993 |
| Largest weekly change | +47.3% (Nov 20, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 333 MG TABLET, manufactured by Wilshire Pharmaceuticals Inc., is $3.5825 per EA (NDC 52536018303), effective Aug 19, 2026.
How has the price of ERYTHROMYCIN DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has risen 5.5%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 333 MG TABLET?
Since Apr 17, 2024, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has ranged from a low of $2.5179 (Aug 21, 2024) to a high of $3.9058 (Dec 11, 2024), with a median of $3.4358 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 333 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN DR 333 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN DR 333 MG TABLET?
ERYTHROMYCIN DR 333 MG TABLET (NDC 52536018303) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.